Status:
RECRUITING
Exposure to Hepatitis E Virus in Occitania, France
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Hepatitis E
Eligibility:
All Genders
18-70 years
Brief Summary
The objective of the proposed work is to determine the seroprevalence of HEV in 2023 in a population of blood donors living in Occitania. Compare the current frequency of anti-HEV IgG and IgM markers...
Detailed Description
Hepatitis E virus (HEV) includes 4 major genotypes. It is now well established that HEV is endemic in most industrialized countries where it is transmitted zoonotically (genotypes 3 and 4) from a larg...
Eligibility Criteria
Inclusion
- blood donors
Exclusion
- \-
Key Trial Info
Start Date :
December 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 14 2024
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06137313
Start Date
December 15 2023
End Date
November 14 2024
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Purpan University Hospital
Toulouse, France, 31059